首页> 外文OA文献 >Induction of metabolism and transport in human intestine: Validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro
【2h】

Induction of metabolism and transport in human intestine: Validation of precision-cut slices as a tool to study induction of drug metabolism in human intestine in vitro

机译:诱导人体小肠中的新陈代谢和转运:精密切割切片的验证可作为研究体外人体小肠中药物代谢诱导的工具

摘要

Induction of drug enzyme activity in the intestine can strongly determine plasma levels of drugs. It is therefore important to predict drug-drug interactions in human intestine in vitro. We evaluated the applicability of human intestinal precision-cut slices for induction studies in vitro. Morphological examination and intracellular ATP levels indicated tissue integrity up to 24 h of incubation, whereas in proximal jejunum slices, the metabolic rate toward most substrates remained at 40 to 50% of initial values. In colon slices, the cytochrome P450 conversions were below the detection limit, but conjugation rates remained relatively constant during incubation. The inducibility of drug-metabolizing enzymes and P-glycoprotein was evaluated using prototypical inducers for five induction pathways. beta-Naphthoflavone (aryl hydrocarbon receptor ligand) induced CYP1A1 (132-fold in colon and 362-fold in proximal jejunum) and UDP glucuronosyltransferase (UGT) 1A6 mRNA (9.8-fold in colon and 3.2-fold in proximal jejunum). In proximal jejunum, rifampicin (RIF) [pregnane X receptor (PXR) ligand] induced CYP3A4 (5.2-fold), CYP2B6 (2-fold), UGT1A6 (2.2-fold), and multidrug resistance-1 (MDR1)/ABCB1 mRNA (2.7-fold), whereas 6 beta-hydroxytestosterone formation (CYP3A4) increased 2-fold. In colon, RIF induced UGT1A6 32-fold and MDR1 2.2-fold. Dexamethasone (glucocorticoid receptor and PXR ligand) induced CYP3A4 mRNA (3.5-fold) and activity (5-fold) in proximal jejunum. Phenobarbital (constitutive androstane receptor activator) induced CYP3A4 (4.1-fold, only in jejunum), CYP2B6 (4.9-fold in colon and 2.3-fold in proximal jejunum), and MDR1/ABCB1 mRNA and CYP3A4 activity (2-fold only proximal jejunum). Quercetin (nuclear factor-E2-related factor 2 activator) induced UGT1A6 mRNA (6.7-fold in colon and 2.2-fold in proximal jejunum). In conclusion, this study shows that human intestinal precision-cut slices are useful to study induction of drug-metabolizing enzymes and transporters in the human intestine.
机译:肠道中药物酶活性的诱导可以强烈确定药物的血浆水平。因此,重要的是在体外预测人肠道中的药物相互作用。我们评估了人类肠道精密切割切片在体外诱导研究中的适用性。形态学检查和细胞内ATP水平表明,在孵育24小时之内组织完整性,而在空肠近端切片中,对大多数底物的代谢率仍保持在初始值的40%至50%。在结肠切片中,细胞色素P450的转化率低于检测极限,但在孵育过程中结合率保持相对恒定。使用原型诱导剂对五个诱导途径评估了药物代谢酶和P-糖蛋白的诱导能力。 β-萘黄酮(芳烃受体配体)诱导CYP1A1(结肠中132倍,空肠近端362倍)和UDP葡萄糖醛糖基转移酶(UGT)1A6 mRNA(结肠9.8倍,空肠近端3.2倍)。在空肠近端,利福平(RIF)[孕烷X受体(PXR)配体]诱导CYP3A4(5.2倍),CYP2B6(2倍),UGT1A6(2.2倍)和多药耐药性1(MDR1)/ ABCB1 mRNA (2.7倍),而6个β-羟基睾丸激素形成(CYP3A4)增加2倍。在结肠中,RIF诱导的UGT1A6是32倍,而MDR1是2.2倍。地塞米松(糖皮质激素受体和PXR配体)在空肠近端诱导CYP3A4 mRNA(3.5倍)和活性(5倍)。苯巴比妥(组成型雄激素受体激活剂)诱导CYP3A4(4.1%,仅在空肠中),CYP2B6(结肠中4.9倍,近端空肠2.3倍)以及MDR1 / ABCB1 mRNA和CYP3A4活性(仅近端空肠2倍) )。槲皮素(核因子-E2相关因子2激活剂)诱导UGT1A6 mRNA(结肠中6.7倍,空肠近端2.2倍)。总之,这项研究表明,人类肠道精确切割切片可用于研究人类肠道中药物代谢酶和转运蛋白的诱导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号